KaydedilenlerDerginizi ekleyin

Dergiler / Cerrahpaşa Tıp Dergisi / 2007 / Cilt: 38 Sayı: 2

Endobronfliyal Giriflimsel Yöntemler ve Intratümöral Kemoterapinin Akciğer Kanserinin Tedavi Stratejisindeki Yeri

Firuz ÇELİKOĞLU
İrfan PAPİLA
Çiğdem PAPİLA
İ.seyhan ÇELİKOĞLU
Sayfa
69–79
Yayın Tarihi
2014-07-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

ÇELİKOĞLU, F., PAPİLA, İ., PAPİLA, Ç., ÇELİKOĞLU, İ. (2014). Endobronfliyal Giriflimsel Yöntemler ve Intratümöral Kemoterapinin Akciğer Kanserinin Tedavi Stratejisindeki Yeri. Cerrahpaşa Tıp Dergisi, Cilt: 38 Sayı: 2, 69–79. https://ajindex.com/articles/984019

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-543
  2. Minna JD, Higgins GA, Glastein E. Cancer of the lung. In: Devita VT, Hellman S, Rosenberg SA (eds). Principles and practice of oncology, 2nd edn.Lppincott, Philadelphia, 1985; 518-526
  3. Jemal A, Murray T,Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics. 2005. Ca Cancer J Clin 2005; 55: 10-30
  4. World health organization: Histological typing of lung cancer and pleural tumors. Berlin, Springer 1999
  5. Cersosomo RJ. Lung cancer: a review. Am J Health Syst Pharm 2002; 59: 611- 642
  6. Matthews M.J. Problems in morphology and behavior of bronchopulmonary malignant disease. Israel L, Chahinian A.P. eds. Lung cancer: Natural History, prognosis and therapy. Academic press New York 1976: 23-62
  7. Group L.L.C.S. Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg 1987; 205: 67-71
  8. Kotlyarov EV, Rukosuyev AA. Long-term results and patterns of disease recurrence after radical operations for lung cancer. J Thorac Cardiovasc Surg 1991; 102: 24-28 [Abstract]
  9. Wingo PA, Tong T,Bolden S, Cancer statistics 1995. Cancer J Clin 1995; 45: 8-30
  10. Nesbitt JC, Putnam JB, Walsh GL, et al. Survival in early stage non-small cell lung cancer. Ann Thorac Surg 1995; 60: 466-472
  11. Spiro SG, Porter JC. Lung Cancer—Where Are We Today? Current Advances in Staging and Nonsurgical Treatment. Am J Resp Critcl Care Med 2002; 166: 1166-1196
  12. Gatzemeir U, Von Pawel L, Gottfried M, et al. Phase III comparative study of high dose Cisplatin versus a combination of paclitaxel and Cisplatin in patients with advanced non-small lung cancer. Proc Am Soc Clin Oncol 1998; 17: 454a
  13. Ning S, Yu N, Brown D.M., Kanekal S, Knox SJ. Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system. Radiother Oncol 1999; 50: 215-223
  14. Trovo MG, Minatel E, Veronesie A, Roncadin M, De Paoli A, Franchin G, et al. Combined radiotherapy and chemotherapy vs. radiotherapy alone in locally advanced bronchogenic carcinoma: a randomized study. Cancer 1990; 65: 400-404
  15. Trovo MG, Minatel E, Franchin G, Boccieri MG, Nascimben O, Bolzicco G, et al. Radiotherapy (RT) versus RT enhanced by cisplatin (CDPG) in stage III non small-cell lung cancer (NSCLC): randomized cooperative study. Lung Cancer 1991; 7: 158
  16. Shaake –Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J. Effects o